ASTX727, ASTX727, Decitabine, ASTX727 clinical trials

A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects with Lower Risk (IPSS Low or Intermediate-1) Myelodysplastic Syndromes (MDS)

This study is testing a new drug called ASTX727 for people with a type of blood condition called myelodysplastic syndromes (MDS). It aims to see how safe the drug is and if it helps improve blood counts.